n.肝胚瘤；肝母细胞瘤

Hepatoblastoma is a rare malignant embryonal liver tumor that primarily affects children.
肝母细胞瘤是一种罕见的恶性胚胎性肝脏肿瘤，主要影响儿童。
The prognosis for patients with hepatoblastoma largely depends on the stage of the disease at diagnosis.
肝母细胞瘤患者的预后在很大程度上取决于诊断时疾病的阶段。
Surgical resection followed by chemotherapy is the standard treatment approach for hepatoblastoma.
手术切除后再进行化疗是治疗肝母细胞瘤的标准方法。
Alpha-fetoprotein (AFP) levels can be elevated in individuals with hepatoblastoma.
在患有肝母细胞瘤的人群中，甲胎蛋白（AFP）水平可能会升高。
Hepatoblastoma most commonly occurs in infants and children under three years old.
肝母细胞瘤最常见于三岁以下的婴幼儿。
Genetic syndromes such as Beckwith-Wiedemann syndrome increase the risk of developing hepatoblastoma.
像贝-维综合征这样的遗传综合症会增加罹患肝母细胞瘤的风险。
Imaging studies like ultrasound, CT scans, and MRI are crucial for diagnosing hepatoblastoma.
超声、CT扫描和MRI等影像学检查对于肝母细胞瘤的诊断至关重要。
Despite its rarity, hepatoblastoma is the most common primary liver malignancy in children.
尽管罕见，但肝母细胞瘤是儿童中最常见的原发性肝脏恶性肿瘤。
A liver transplant may be necessary in cases where the entire liver is affected by hepatoblastoma.
如果整个肝脏受到肝母细胞瘤的影响，可能需要进行肝脏移植。
Targeted therapies and immunotherapies are emerging as promising treatment options for hepatoblastoma.
针对性疗法和免疫疗法作为肝母细胞瘤的治疗选择正在崭露头角。